Anastomosis Leaking

2

Review clinical trials related to Anastomosis Leaking. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

This study will evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) on treating emerging indications (i.e., conditions that have shown to potentially benefit from HBOT) using the Multicenter Registry for Hyperbaric Oxygen Treatment. The study team aims to collect ongoing data on how well HBOT treats these emerging indications, and to add these data to the growing HBO Registry. The research team hypothesizes that HBOT will result in improvements of the condition of the various emerging indications.

Participants needed: 100
Trial details
Phase: Phase 4Biological sex: AllType: InterventionalSponsor: Jay C. Buckey Jr.Updated: May 5, 2026
Eligibility criteria

Patients referred for HBOT with an emerging indication

Contraindication to hyperbaric oxygen treatment (untreated seizures, pneumothora... [+1]

Status: Not yet recruiting

Effect of Preserving the Left Colic Artery on Proximal Bowel Perfusion

Patients with rectal or rectosigmoid cancer undergoing radical resection will be randomly assigned to either high-tie (HT) or low-tie (LT) ligation of the Inferior Mesenteric Artery (IMA). Proximal bowel blood perfusion will be measured using Laser Speckle Contrast Imaging, and the perfusion characteristics will be compared between the two ligation groups. Additionally, for participants randomized to the LT group, an embedded prospective cohort sub-study will be performed. This sub-study involves controlled, temporary intraoperative occlusion of the preserved Left Colic Artery (LCA). During this temporary occlusion, LSCI will be used to assess the resulting changes in colonic perfusion, specifically measuring outcomes like the ischemic demarcation line (LOD) retraction distance, to further investigate the functional contribution of the preserved LCA. The overall trial aims to determine the optimal IMA ligation strategy based on objective perfusion data and a deeper understanding of LCA's role.

Participants needed: 143
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Ningbo Medical Center Lihuili HospitalUpdated: May 21, 2025
Eligibility criteria

a confirmed diagnosis based on pathological reports; [+1]

a history of previous abdominal surgery or neoadjuvant chemotherapy/radiation af... [+2]